Charles T. Bernhardt
2019
In 2019, Charles T. Bernhardt earned a total compensation of $187.3K as Former Interim Chief Financial Officer at Cellectar Biosciences.
Compensation breakdown
| Other | $187,313 |
|---|---|
| Total | $187,313 |
Bernhardt received $187.3K in other compensation, accounting for 100% of the total pay in 2019.
Rankings
In 2019, Charles T. Bernhardt's compensation ranked 13,496th out of 13,971 executives tracked by ExecPay. In other words, Bernhardt earned more than 3.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,496 out of 13,971 | 3rd |
Division Manufacturing | 5,488 out of 5,695 | 4th |
Major group Chemicals And Allied Products | 2,130 out of 2,194 | 3rd |
Industry group Drugs | 1,830 out of 1,880 | 3rd |
Industry Pharmaceutical Preparations | 1,355 out of 1,392 | 3rd |
Source: SEC filing on April 28, 2020.
Bernhardt's colleagues
We found four more compensation records of executives who worked with Charles T. Bernhardt at Cellectar Biosciences in 2019.